The following serious adverse reactions are described below or elsewhere in the prescribing information: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice
Ask yourself, do these retail centers selling prescriptions really have expertise in nutrition, physiology, pharmacology, and metabolism
While risk is poorly characterized in smaller racial and ethnic groups in the U.S., multiple studies have reported differences in risk among Hispanic, nonHispanic Black and nonHispanic White individuals
Less Common Joint pain or stiffness Numbness or tingling These typically resolve with continued use or dose adjustment
Congress passed last year
BPC 157 can be used by a range of athletes and individuals focused on recovery and joint health